Erenumab versus topiramate for the prevention of migraine - a randomised, double-blind, active-controlled phase 4 trial.

Uwe ReuterMarc EhrlichAstrid GendollaAxel HeinzeJan KlattShihua WenPeggy Hours-ZesigerJacqueline NickischChristian SiederChristian HentschkeMonika Maier-Peuschel

Published in: Cephalalgia : an international journal of headache (2021)

Erenumab demonstrated a favourable tolerability and efficacy profile compared to topiramate.Trial registration: ClinicalTrials.gov NCT03828539, URL: https://clinicaltrials.gov/ct2/show/NCT03828539.

Keyphrases

double blind
placebo controlled
phase iii
open label
phase ii
clinical trial
study protocol
image quality
computed tomography
dual energy
contrast enhanced
randomized controlled trial
positron emission tomography
magnetic resonance imaging